Bill
S 2283
"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.*
2024-2025 Regular Session
Introduced by Renee Burgess and 8 co-sponsors
New Jersey bill authorizes regulated psilocybin production and clinical administration by licensed providers for treating mental health conditions despite federal prohibition.
Reported out of Senate Committee with Amendments, 2nd Reading